Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 20/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15935573 | 0.92 | SYK (0.68) | SYK | |
| SCHEMBL14839074 | 0.89 | SYK (1.00) | SYK | |
| SCHEMBL15910600 | 0.88 | SYK (1.00) | SYK | |
| SCHEMBL16743276 | 0.85 | SYK (0.80) | SYK | |
| SCHEMBL15910909 | 0.82 | SYK (0.89) | SYK | |
| SCHEMBL15910572 | 0.80 | SYK (0.80) | SYK | |
| SCHEMBL14839247 | 0.80 | SYK (0.66) | SYK | |
| SCHEMBL16743231 | 0.80 | SYK (0.71) | SYK | |
| SCHEMBL14839154 | 0.80 | SYK (0.67) | SYK | |
| SCHEMBL14838960 | 0.79 | SYK (0.88) | SYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115785735-B | High-refractive-index ink for pure organic ink-jet printing and preparation method thereof | 西安思摩威新材料有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-117106374-A | Glue composition and cured film formed by same | 西安思摩威新材料有限公司 | 2023-11-24 | — | — | CN | disclosed |
| CN-115785735-A | High-refractive-index ink for pure organic ink-jet printing and preparation method thereof | 西安思摩威新材料有限公司 | 2023-03-14 | — | — | CN | disclosed |
| CN-115558429-A | Glue composition and cured film formed by same | 西安思摩威新材料有限公司 | 2023-01-03 | — | — | CN | disclosed |
| EP-2762506-B1 | (METH)ACRYLOYL-TERMINATED POLYISOBUTYLENE POLYMER, METHOD FOR PRODUCING SAME, AND ACTIVE ENERGY RAY-CURABLE COMPOSITION | KANEKA CORP (JP) | 2022-09-07 | — | — | EP | disclosed |
| WO-2019151549-A1 | HIGH REFRACTIVE INDEX ACRYLIC MONOMER AND PHOTOCURABLE COMPOSITION USING SAME | 에스엠에스주식회사 | 2019-08-08 | — | — | WO | disclosed |
| US-9708424-B2 | (Meth)acryloyl-terminated polyisobutylene polymer, method for producing the same, and active energy ray-curable composition | KANEKA CORPORATION (JP) | 2017-07-18 | — | — | US | disclosed |
| US-20170051093-A1 | (METH)ACRYLOYL-TERMINATED POLYISOBUTYLENE POLYMER, METHOD FOR PRODUCING THE SAME, AND ACTIVE ENERGY RAY-CURABLE COMPOSITION | KANEKA CORP (JP) | 2017-02-23 | — | — | US | disclosed |
| US-9512247-B2 | (Meth)acryloyl-terminated polyisobutylene polymer, method for producing the same, and active energy ray-curable composition | KANEKA CORPORATION (JP) | 2016-12-06 | — | — | US | disclosed |
| US-9145414-B2 | 1,2,4-triazine-6-carboxamide derivative | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2015-09-29 | — | — | US | disclosed |
| US-9145414-B2 | 1,2,4-triazine-6-carboxamide derivative | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2015-09-29 | — | — | US | disclosed |
| US-9145414-B2 | 1,2,4-triazine-6-carboxamide derivative | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2015-09-29 | — | — | US | disclosed |
| US-20150198740-A1 | ORGANIC-INORGANIC HYBRID COMPOSITION, PRODUCTION METHOD FOR SAME, AND OPTICAL SHEET AND OPTICAL DEVICE OF SAME | CHANGKANG CHEMICAL CO., LTD. (KR) | 2015-07-16 | — | — | US | disclosed |
| US-20140343038-A1 | 1,2,4-TRIAZINE-6-CARBOXAMIDE DERIVATIVE | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2014-11-20 | — | — | US | disclosed |
| US-20140343038-A1 | 1,2,4-TRIAZINE-6-CARBOXAMIDE DERIVATIVE | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2014-11-20 | — | — | US | disclosed |
| US-20140343038-A1 | 1,2,4-TRIAZINE-6-CARBOXAMIDE DERIVATIVE | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2014-11-20 | — | — | US | disclosed |
| US-20140243444-A1 | (METH)ACRYLOYL-TERMINATED POLYISOBUTYLENE POLYMER, METHOD FOR PRODUCING THE SAME, AND ACTIVE ENERGY RAY-CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2014-08-28 | — | — | US | disclosed |
| EP-2762506-A1 | (METH)ACRYLOYL-TERMINATED POLYISOBUTYLENE POLYMER, METHOD FOR PRODUCING SAME, AND ACTIVE ENERGY RAY-CURABLE COMPOSITION | Kaneka Corporation (JP) | 2014-08-06 | — | — | EP | disclosed |
| EP-2762476-A1 | 1,2,4-TRIAZINE-6-CARBOXAMIDE DERIVATIVE | Taiho Pharmaceutical Co., Ltd. (JP) | 2014-08-06 | — | — | EP | disclosed |
| WO-2013047813-A1 | 1,2,4-TRIAZINE-6-CARBOXAMIDE DERIVATIVE | 大鵬薬品工業株式会社 (JP) | 2013-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140343038-A1 | 1,2,4-TRIAZINE-6-CARBOXAMIDE DERIVATIVE | SYK, BTK, JAK2 | SYK 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.